Altered T cell responses in children with autism

Brain, Behavior, and Immunity

Volumn 25, Issue 5, 2011, Pages 840-849

  Ashwood, Paul ^a,b   Krakowiak, Paula ^a   Hertz Picciotto, Irva ^a,b   Hansen, Robin ^a,b   Pessah, Isaac N ^b   Van de Water, Judy ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Behavior; Cell surface markers; Cytokines; Immunology; Lymphocytes

Indexed keywords

CD134 ANTIGEN; CD137 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ARTICLE; AUTISM; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TETANUS; TH1 CELL; TH2 CELL;

ADAPTIVE IMMUNITY; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MALE; PHYTOHEMAGGLUTININS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TETANUS TOXIN;

EID: 79957896374     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.09.002     Document Type: Article

References (82)

1. Akbar A.N., Vukmanovic-Stejic M., Taams L.S., Macallan D.C. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat. Rev. Immunol. 2007, 7(3):231-237.
2. Arch R.H., Thompson C.B. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB. Mol. Cell. Biol. 1998, 18(1):558-565.
3. Ashwood P., Wakefield A.J. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 2006, 173(1-2):126-134.
4. Ashwood P., Anthony A., Torrente F., Wakefield A.J. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J. Clin. Immunol. 2004, 24(6):664-673.
5. Ashwood P., Wills S., Van de Water J. The immune response in autism: a new frontier for autism research. J. Leukoc. Biol. 2006, 80(1):1-15.
6. Ashwood P., Enstrom A., Krakowiak P., Hertz-Picciotto I., Hansen R.L., Croen L.A., Ozonoff S., Pessah I.N., Van de Water J. Decreased transforming growth factor β1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J. Neuroimmunol. 2008, 204(1-2):149-153.
7. Ashwood P., Nguyen D.V., Hessl D., Hagerman R.J., Tassone F. Plasma cytokine profiles in Fragile X subjects: Is there a role for cytokines in the pathogenesis?. Brain Behav. Immun. 2010, 24(6):898-902.
8. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011, 25(1):40-45.
9. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR 2000, American Psychiatric Association, American Psychiatric Association Publishing Inc., Washington, DC, USA. 4th ed.
10. Atladóttir H.O., Pedersen M.G., Thorsen P., Mortensen P.B., Deleuran B., Eaton W.W., Parner E.T. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 2009, 124(2):687-694.
11. Atladóttir H.O., Thorsen P., Schendel D.E., Østergaard L., Lemcke S., Parner E.T. Association of hospitalization for infection in childhood with diagnosis of autism spectrum disorders: a Danish cohort study. Arch Pediatr. Adolesc. Med. 2010, 164(5):470-477.
12. Brook G.A., Plate D., Franzen R., Martin D., Moonen G., Schoenen J., Schmitt A.B., Noth J., Nacimiento W. Spontaneous longitudinally orientated axonal regeneration is associated with the Schwann cell framework within the lesion site following spinal cord compression injury of the rat. J. Neurosci. Res. 1998, 53:51-65.
13. Cabanlit M., Wills S., Goines P., Ashwood P., Van de Water J. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann. NY Acad. Sci. 2007, 1107:92-103.
14. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S., Elia M., Schneider C., Melmed R., Sacco R., Persico A.M., et al. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci. USA 2006, 103(45):16834-16839.
15. Campbell D.B., D'Oronzio R., Garbett K., Ebert P.J., Mirnics K., Levitt P., Persico A.M. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann. Neurol. 2007, 62(3):243-250.
16. Chez M.G., Dowling T., Patel P.B., Khanna P., Kominsky M. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr. Neurol. 2007, 36(6):361-365.
17. Comi A.M., Zimmerman A.W., Frye V.H., Law P.A., Peeden J.N. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 1999, 14(6):388-394.
18. Connolly A.M., Chez M., Streif E.M., Keeling R.M., Golumbek P.T., Kwon J.M., Riviello J.J., Robinson R.G., Neuman R.J., Deuel R.M. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry 2006, 59(4):354-363.
19. Cooper D., Bansal-Pakala P., Croft M. 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur. J. Immunol. 2002, 32(2):521-529.
20. Croen L.A., Grether J.K., Yoshida C.K., Odouli R., Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch. Pediatr. Adolesc. Med. 2005, 159(2):151-157.
21. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?. Nat. Rev. Immunol. 2003, 3(8):609-620.
22. Curran L.K., Newschaffer C.J., Lee L.C., Crawford S.O., Johnston M.V., Zimmerman A.W. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 2007, 120:e1386-e1392.
23. Denney D.R., Frei B.W., Gaffney G.R. Lymphocyte subsets and interleukin-2 receptors in autistic children. J. Autism Dev. Disord. 1996, 26(1):87-97.
24. Derecki N.C., Cardani A.N., Yang C.H., Quinnies K.M., Crihfield A., Lynch K.R., Kipnis J. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J. Exp. Med. 2010, 207(5):1067-1080.
25. Enstrom A.M., Van de Water J.A., Ashwood P. Autoimmunity in autism. Curr. Opin. Investig. Drugs 2009, 10:463-473.
26. Enstrom A.M., Lit L., Onore C.E., Gregg J.P., Hansen R.L., Pessah I.N., Hertz-Picciotto I., Van de Water J.A., Sharp F.R., Ashwood P. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav. Immun. 2009, 23(1):124-133.
27. Enstrom A., Krakowiak P., Onore C., Pessah I.N., Hertz-Picciotto I., Hansen R.L., Van de Water J.A., Ashwood P. Increased IgG4 levels in children with autism disorder. Brain Behav. Immun. 2009, 23:389-395.
28. Enstrom A., Onore C., Van de Water J., Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav. Immun. 2010, 24(1):64-71.
29. Garbett K., Ebert P.J., Mitchell A., Lintas C., Manzi B., Mirnics K., Persico A.M. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol. Dis. 2008, 30(3):303-311.
30. Grigorenko E.L., Han S.S., Yrigollen C.M., Leng L., Mizue Y., Anderson G.M., Mulder E.J., de Bildt A., Minderaa R.B., Volkmar F.R., Chang J.T., Bucala R. Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics 2008, 122(2):438-445.
31. Gupta S., Aggarwal S., Rashanravan B., Lee T. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J. Neuroimmunol. 1998, 85(1):106-109.
32. Hamilton J.A., Anderson G.P. GM-CSF biology. Growth Factors 2004, 22(4):225-231.
33. Herman G.E., Butter E., Enrile B., Pastore M., Prior T.W., Sommer A. Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly. Am. J. Med. Genet. A 2007, 143:589-593.
34. Hertz-Picciotto I., Croen L.A., Hansen R., Jones C.R., Van de Water J., Pessah I.N. The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ. Health Perspect. 2006, 114:1119-1125.
35. Heuer L., Ashwood P., Schauer J., Goines P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., Pessah I.N., Van de Water J. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res. 2008, 1(5):275-283.
36. Jyonouchi H., Sun S., Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 2001, 120:170-179.
37. Jyonouchi H., Geng L., Cushing-Ruby A., Quraishi H. 2008. Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J. Neuroinflammation 2008, 5:52-59.
38. Kalinkovich A., Spiegel A., Shivtiel S., Kollet O., Jordaney N., Piacibello W., Lapidot T. Blood-forming stem cells are nervous: direct and indirect regulation of immature human CD34+ cells by the nervous system. Brain Behav. Immun. 2009, 23(8):1059-1065.
39. Kannan Y., Moriyama M., Sugano T., Yamate J., Kuwamura M., Kagaya A., Kiso Y. Neurotrophic action of interleukin 3 and granulocyte-macrophage colony-stimulating factor on murine sympathetic neurons. Neuroimmunomodulation 2000, 8:132-141.
40. Kipnis J., Cohen H., Cardon M., Ziv Y., Schwartz M. T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc. Natl. Acad. Sci. USA 2004, 101:8180-8185.
41. Krüger C., Laage R., Pitzer C., Schäbitz W.R., Schneider A. The hematopoietic factor GM-CSF (granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro. BMC Neurosci. 2007, 8:88-95.
42. Kwajah M.M.S., Schwarz H. CD137 ligand signaling induces human monocyte to dendritic cell differentiation. Eur. J. Immunol. 2010, 40(7):1938-1949.
43. Lee L.C., Zachary A.A., Leffell M.S., Newschaffer C.J., Matteson K.J., Tyler J.D., Zimmerman A.W. HLA-DR4 in families with autism. Pediatr. Neurol. 2006, 35(5):303-307.
44. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.-M., Ji L., Brown T., Malik M. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 2009, 207(1-2):111-116.
45. Lintas C., Sacco R., Garbett K., et al. Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression. Mol. Psychiatry 2009, 14:705-718.
46. McLay R.N., Kimura M., Banks W.A., Kastin A.J. Granulocyte macrophage colony stimulating factor crosses the blood brain and blood spinal cord barriers. Brain 1997, 120:2083-2091.
47. Min L., Mohammad Isa S.A., Shuai W., Piang C.B., Nih F.W., Kotaka M., Ruedl C. Cutting edge: granulocyte-macrophage colony-stimulating factor is the major CD8+ T cell-derived licensing factor for dendritic cell activation. J. Immunol. 2010, 184(9):4625-4629.
48. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Courtney P., Altaye M., Wills-Karp M. Elevated cytokine levels in children with autism spectrum disorder. J. Neuroimmunol. 2005, 172(1-2):198-205.
49. Molloy C.A., Morrow A.L., Meinzen-Derr J., Dawson G., Bernier R., Dunn M., Hyman S.L., McMahon W.M., Goudie-Nice J., Hepburn S., Minshew N., et al. Familial autoimmune thyroid disease as a risk factor for regression in children with autism spectrum disorder: a CPEA study. J. Autism Dev. Disord. 2006, 36(3):317-324.
50. Mostafa G.A., Al Shehab A., Fouad N.R. Frequency of CD4+CD25high regulatory T cells in the peripheral blood of Egyptian children with autism. J. Child Neurol. 2010, 25(3):328-335.
51. Muhle R., Trentacoste S.V., Rapin I. The genetics of autism. Pediatrics 2004, 113(5):472-486.
52. Niehus R., Lord C. Early medical history of children with autism spectrum disorders. J. Dev. Behav. Pediatr. 2006, 27(Suppl. 2):S120-S127.
53. Okada K., Hashimoto K., Iwata Y., Nakamura K., Tsujii M., Tsuchiya K.J., Sekine Y., Suda S., Suzuki K., Sugihara G., Matsuzaki H., Mori N. Decreased serum levels of transforming growth factor-β1 in patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31(1):187-190.
54. Onore C., Krakowiak P., Enstrom A., Hansen R., Hertz-Picciotto I., Van de Water J., Ashwood P. Decreased cellular IL-23 production in children with autism spectrum disorders. J. Neuroimmunol. 2009, 216(1-2):126-129.
55. Plioplys A.V., Greaves A., Kazemi K., Silverman E. Lymphocyte function in autism and Rett syndrome. Neuropsychobiology 1994, 29(1):12-16.
56. Poulton T.A., Gallagher A., Potts R.C., Beck J.S. Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulation. Immunology 1988, 64(3):419-425.
57. Reddy P.H., Manczak M., Zhao W., Nakamura K., Bebbington C., Yarranton G., Mao P. Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's disease and multiple sclerosis. J. Neurochem. 2009, 111(6):1514-1528.
58. Rosen N.J., Yoshida C.K., Croen L.A. Infection in the first 2years of life and autism spectrum disorders. Pediatrics 2007, 119(1):61-69.
59. Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10(7):490-500.
60. Schäbitz W.R., Krüger C., Pitzer C., Weber D., Laage R., Gassler N., Aronowski J., Mier W., Kirsch F., Dittgen T., Bach A., Sommer C., Schneider A. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J. Cereb. Blood Flow Metab. 2008, 28(1):29-43.
61. Serajee F.J., Zhong H., Mahbubul Huq A.H. Association of Reelin gene polymorphisms with autism. Genomics 2006, 87:75-83.
62. Shevach E.M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006, 25(2):195-201.
63. Silva S.C., Correia C., Fesel C., Barreto M., Coutinho A.M., Marques C., Miguel T.S., Ataide A., Bento C., Borges L., Oliveira G., Vicente A.M. Autoantibody repertoires to brain tissue in autism nuclear families. J. Neuroimmunol. 2004, 152(1-2):176-182.
64. Skaar D.A., Shao Y., Haines J.L., et al. Analysis of the RELN gene as a genetic risk factor for autism. Mol. Psychiatry 2005, 10:563-571.
65. Smith K.A. Interleukin-2: inception, impact, and implications. Science 1988, 240(4856):1169-1176.
66. So T., Lee S.W., Croft M. Immune regulation and control of regulatory T cells by OX40 and 4-1BB. Cytokine Growth Factor Rev. 2008, 19(3-4):253-262.
67. Sonderegger I., Iezzi G., Maier R., Schmitz N., Kurrer M., Kopf M. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 2008, 205(10):2281-2294.
68. Song J., So T., Cheng M., Tang X., Croft M. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 2005, 22(5):621-631.
69. Stubbs E.G. Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J. Autism Child Schizophr. 1976, 6:269-274.
70. Stubbs E.G., Crawford M.L. Depressed lymphocyte responsiveness in autistic children. J. Autism Child Schizophr. 1977, 7(1):49-55.
71. MMWR Surveill. Summ., 2009. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators, Centers for Disease Control and Prevention (CDC) 58 (10) 1-20.
72. Sweeten T.L., Posey D.J., Shankar S., McDougle C.J. High nitric oxide production in autistic disorder: a possible role for interferon-γ. Biol. Psychiatry 2004, 55(4):434-437.
73. Todd R.D., Hickok J.M., Anderson G.M., Cohen D.J. Antibrain antibodies in infantile autism. Biol. Psychiatry 1988, 23(6):644-647.
74. Torres A.R., Sweeten T.L., Cutler A., Bedke B.J., Fillmore M., Stubbs E.G., Odell D. The association and linkage of the HLA-A2 class I allele with autism. Hum. Immunol. 2006, 67(4-5):346-351.
75. Tsuchiya K.J., Hashimoto K., Iwata Y., Tsujii M., Sekine Y., Sugihara G., Matsuzaki H., Suda S., Kawai M., Nakamura K., Minabe Y., Yagi A., Iyo M., Takei N., Mori N. Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. Biol. Psychiatry 2007, 62:1056-1058.
76. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57(1):67-81.
77. Warren R.P., Singh V.K., Cole P., Odell J.D., Pingree C.B., Warren W.L., DeWitt C.W., McCullough M. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics 1992, 36(4):203-207.
78. Warren R.P., Yonk J., Burger R.W., Odell D., Warren W.L. DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein. Neuropsychobiology 1995, 31(2):53-57.
79. Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D.G., Van de Water J. Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav. Immun. 2009, 23(1):64-74.
80. Yonk L.J., Warren R.P., Burger R.A., Cole P., Odell J.D., Warren W.L., White E., Singh V.K. CD4+ helper T cell depression in autism. Immunol. Lett. 1990, 25(4):341-345.
81. Ziv Y., Schwartz M. Immune-based regulation of adult neurogenesis: implications for learning and memory. Brain Behav. Immun. 2008, 22:167-176.
82. Ziv Y., Ron N., Butovsky O., Landa G., Sudai E., Greenberg N., Cohen H., Kipnis J., Schwartz M. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 2006, 9:268-275.